• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Senator Calls For Delay in Making Final Rules for MU Stage 3

by Fred Pennic 09/17/2015 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Sen. Alexander: Gov't Should Not Force Meaningful Use Adoption
Sen. Lamar Alexander

Sen. Lamar Alexander (R-Tenn.), chairman of the Senate Health, Education, Labor and Pensions Committee (HELP), on Wednesday called for a delay until January 1, 2017, of making final rules for Meaningful Use Stage 3. Alexander is urging that MU Stage 3 requirements should then be phased in at a rate that reflects how successfully the program is being implemented. Additionally, the modified rules proposed for MU Stage 2 should be adopted immediately because it will help most doctors and hospitals to comply with the government’s requirements.

“Patients need an interoperable system that enables doctors and hospitals to share their electronic health records, but the government, doctors and hospitals need time to do it right,” Alexander told a senate hearing.  “Some hospitals have told me they are ‘terrified’ by the prospect of stage three.  It does not help patients to makes these massive changes fast and wrong.  It does help patients to do this deliberately and correctly so that hospitals and doctors embrace the changes instead of dread them.”

Since 2009, the federal government has spent more than $30 billion to encourage the nearly 500,000 physicians and more than 5,000 hospitals who serve Medicare and Medicaid recipients to establish EHR systems. About half of these doctors and most hospitals have established such systems. Beginning this year, the government is assessing penalties on those who have not. About 257,000 physicians have begun losing 1 percent of their Medicare reimbursements and 200 hospitals may be losing more than that, the senator said.

Alexander states that all hospitals and most physicians met the requirements of the first stage of the MU program; however, Stage 2 MU requirements are so complex that only about 12 percent of eligible physicians and 40 percent of eligible hospitals have been able to comply. “That is why the government should immediately adopt its proposed modifications to the stage two requirements—so physicians and hospitals have time to adapt to these huge changes,” he said.

“Our senate health committee has held five hearings on this electronic health records program,” Alexander said.  “Many of those who testified have urged us to delay making final these stage three requirements in order to really help patients. I look forward to working with Senator Murray, Secretary Burwell and other members of the administration on finding the best ways to modify this program and these requirements.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |